NDC 68180-970

Levothyroxine Sodium 0.112 mg tablet

On the label: Lupin Pharmaceuticals, Inc..

Where it's made

Lupin Limited

Dhar, India · makes it and packages it

Problems found, fixed voluntarily Last FDA inspection Sep 27, 2024. 4 inspections on record.

Recalls

• Dec 20, 2024 · Class II · Terminated
  Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
  Lots: Lot# LA01276, Exp Date: 07/2026

Product details

Generic drug

Levothyroxine: see every company that makes it

Form

tablet, oral

Strength

0.112 mg

Approval

ANDA ANDA209713

On the market since

Mar 20, 2019

Package NDCs

68180-970-01 68180-970-02 68180-970-03 68180-970-09

Official label

DailyMed (National Library of Medicine), updated Mar 19, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?